- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- December 2019
- 233 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2022
- 117 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
The Medical Linear Accelerator (MLA) is a type of medical device used in radiation therapy to treat cancer. It is a type of particle accelerator that produces a beam of high-energy X-rays or electrons to destroy cancer cells. The MLA is used to target tumors with high precision, while minimizing damage to surrounding healthy tissue. It is also used to treat benign tumors, as well as to provide palliative care for patients with advanced cancer.
MLAs are used in a variety of settings, including hospitals, clinics, and private practices. They are typically used in conjunction with other treatments, such as chemotherapy and surgery. The MLA market is highly competitive, with a number of manufacturers offering a range of products.
Some of the major companies in the Medical Linear Accelerator market include Varian Medical Systems, Elekta, Accuray, IBA, and Hitachi. Show Less Read more